NCT05662917

Brief Summary

The question of the end of life is a major public health issue. In the field of palliative care, the notion of anticipation is central for people with a serious and progressive illness. Indeed, an important consideration for general practitioners is the need to anticipate the disease's evolution and the uncomfortable symptoms (physical or psychological) the patient is likely to experience. This approach aims to relieve the patient without delay and thus improve comfort to ensure an acceptable quality of life for patients and their families. Even if the usefulness of anticipatory prescribing seems obvious, their use is not generalized to all palliative care patients. Caregivers are confronted with obstacles to the implementation of these prescriptions, particularly with regard to the relationship with the patient. It can then be assumed that patients' experiences and perceptions may influence symptom management and the use of anticipatory prescriptions. It seems essential to explore this subject. For this purpose, the investigator will carry out a qualitative study based on individual semi-structured interviews with palliative care patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 23, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

March 10, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2023

Completed
Last Updated

August 8, 2023

Status Verified

August 1, 2023

Enrollment Period

9 months

First QC Date

December 12, 2022

Last Update Submit

August 7, 2023

Conditions

Palliative Care

Keywords

Palliative careAdvance care planningAnticipatory prescribingEnd of lifePatient experiences

Outcome Measures

Primary Outcomes (1)

  • The primary outcome is patient views on the use of anticipatory prescribing.

    The interview consists in exploring the participants' experiences (feelings, representations), expectations and difficulties concerning the use of anticipatory prescribing. Interviews will be audio recorded. The verbatim will be transcribed for qualitative analysis by inductive thematic type, in order to bring out the main ideas and hypotheses.

    The outcome will be collected at Day 1-End of study visit

Study Arms (1)

Palliative care patients

* Palliative care patients * Suffering from a serious and progressive illness (whatever it is) * Hospitalized in a palliative care unit or followed at home by the hospital's mobile palliative care team

Behavioral: Individual semi-structured interviews

Interventions

Individual semi-structured interviewsBEHAVIORAL

After information and written consent, the investigator will interview the participants through a semi-structured individual interview (conducted by an interview guide). The interview is expected to last 45 minutes (variable depending on the subject). It will be recorded by dictaphone, respecting the anonymity of the participant throughout the interview. The subject's participation will end after the interview.

Palliative care patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population concerns patients in palliative situation, either hospitalized in palliative care unit or followed at home by the Mobile Palliative Care Team. The number of subjects required is estimated at a minimum of 15 participants (depend on data saturation)

You may qualify if:

  • Persons of all genders
  • Persons 18 years of age and older
  • In a palliative care situation of any serious illness
  • Persons hospitalized in palliative care unit at the Givors hospital or followed at home by the Mobile Palliative Care Team
  • Patients who have received full information about the study and signed a written consent.

You may not qualify if:

  • Persons under legal protection
  • Persons unable to express their consent, making it impossible to conduct interviews: dysarthria, cognitive disorders, mental confusion, altered state of consciousness
  • Pregnant or breastfeeding persons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Givors Hospital Center - Multidisciplinary medicine and palliative care department

Givors, 69700, France

RECRUITING

MeSH Terms

Conditions

Death

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Manon JULLIAN

    Multidisciplinary medicine and palliative care department

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Manon JULLIAN

CONTACT

4 78 07 30 91manonjullian@hotmail.fr

Julien TRAUTMANN, MD

CONTACT

4 78 07 31 38jtrautmann@ch-givors.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2022

First Posted

December 23, 2022

Study Start

March 10, 2023

Primary Completion

December 10, 2023

Study Completion

December 10, 2023

Last Updated

August 8, 2023

Record last verified: 2023-08

Locations

FR(1)